On October 25, 2026, South Korea reported a record current account surplus in the second quarter, surpassing the combined surpluses of Germany and Japan, primar
On October 25, 2026, Malaysia's Prime Minister Anwar Ibrahim announced that SoftBank's Masayoshi Son has selected multiple locations in Malaysia for a substanti
Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of 36.7% following progression on or after immunotherapy plus chemotherapyAn early median progression-free survival of 6.9 months was observedSignificant unmet need remains for patients who have progressed on an immunotherapy-containing regimen, with the average progression-free survival below 4 months for standard of care docetaxel Data represent the third global Phase 2 dataset for pumitamig in lung cancer and reinforce its potential to improve outcomes over current standards of care MAINZ, Germany, and PRINCETON, USA, October 25, 2026 - BioNTech SE (Nasdaq: BNTX, 'BioNTech”) and Bristol Myers Squibb Company (NYSE: BMY, 'BMS”) today announced first data from the global Phase 2 ROSETTA Lung-107 clinical trial (NCT06841055) evaluating pumitamig, an investigational PD-L1xVEGF-A bispecific immunomodulator (BNT327/BMS986545), in combination with docetaxel in patients with metastatic non-small cell lung cancer ('NSCLC”) whose disease progressed on or after first-line immunotherapy plus chemotherapy.
Indian benchmarks track overnight US flows and crude prices; traders watch RBI commentary and FII activity for direction.
